C0436548||Transcranial magnetic stimulation
C3887640||astrocytosis
C0023810||lipopolysaccharide
C0014072||experimental autoimmune encephalomyelitis
C0014072||Experimental autoimmune encephalomyelitis
C0014072||Experimental autoimmune encephalomyelitis
C0086272||valid experimental model
C0026769||multiple sclerosis
C0021368||chronic neuroinflammatory condition
C3714787||central nervous system
C0023810||bacterial lipopolysaccharide
C1155000||activation of reactive immune cells
C0032930||triggering
C0021368||neuroinflammation
C2603343||studies
C0436548||transcranial magnetic stimulation
C0436548||transcranial magnetic stimulation
C0015264||exert
C0436548||transcranial magnetic stimulation
C0021368||neuroinflammation
C0014072||Experimental autoimmune encephalomyelitis
C0086893||Dark Agouti rats
C0014072||Experimental autoimmune encephalomyelitis
C0069428||myelin oligodendrocyte glycoprotein
C4084924||Clinical evaluation
C0426980||motor symptoms
C0936012||analyzed
C0028128||nitric oxide
C0023810||lipopolysaccharide
C0065054||lipopolysaccharide-binding protein
C0019637||histologic exam
C0004112||astrocyte
C0487602||immunostaining
C0487602||Nissl staining
C0006104||brain
C0007610||pyknotic nuclei
C0436548||transcranial magnetic stimulation
C0234130||motor
C0014072||Experimental autoimmune encephalomyelitis
C0442797||decreasing
C0004112||astrocytes
C0443146||autoimmune attack
C0028128||nitric oxide
C0023810||lipopolysaccharide
C0065054||lipopolysaccharide-binding protein
C3714787||central nervous system
C0003062||animals
C0006104||brain
C0184511||improved
C0007610||pyknotic nuclei
C0436548||Transcranial magnetic stimulation
C3887640||astrocytosis
C0023810||lipopolysaccharide
C0014072||Experimental autoimmune encephalomyelitis
C0436548||transcranial magnetic stimulation
C0087111||promising treatment
C0021368||neuroinflammatory conditions
C0026769||multiple sclerosis